BioNexus Gene Lab Corp Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 0.09M-0.30M1.09M1.33M-0.25M-2.59M-1.59M
Depreciation and Depletion 0.04M0.04M0.09M0.09M0.09M0.08M0.10M
Share-based Compensation 0.51M
Gains from Investment Securities -0.01M-0.01M0.71M0.52M-0.17M0.51M0.14M
Asset Writedowns and Impairment 0.00M0.00M0.00M0.01M0.04M
Non-cash Items -1.94M-2.35M
Cash from Operations -0.27M-0.22M0.55M0.01M0.55M-1.82M-2.23M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.01M0.01M0.02M0.01M0.03M0.05M
Depreciation & Amortization (CF) 0.04M0.04M0.09M0.09M0.09M0.08M0.10M
Change in Working Capital
Change in Receivables 0.01M0.41M0.58M0.54M0.65M0.15M
Change in Inventory 0.02M0.01M0.15M-0.35M0.54M-0.16M
Change in Account Payables -0.46M-0.03M-0.52M-1.18M-0.12M-0.38M0.20M
Change in Accured Expenses 0.04M-0.02M
Change in Taxes 0.03M0.07M0.01M-0.04M
Other Working Capital Changes 0.11M-0.01M0.08M-0.13M0.08M0.10M
Investing Activities
Capital Expenditures -0.04M0.01M0.42M0.00M0.05M0.15M0.23M
Sales of Property, Plant and Equipment 1.47M
Divestments 0.02M0.12M0.06M
Change in Acquisitions & Divestments 0.01M0.03M1.07M
Cash from Investing Activities -0.05M-0.01M1.32M-0.49M-0.45M-1.79M0.42M
Financing Activities
Cash from Financing Activities 0.74M-0.18M-0.00M-0.03M0.11M6.27M0.14M
Dividend Payments
Dividends Paid - Common 0.01M0.01M
Additional items
Exchange Rate Effect 0.01M0.06M-0.15M-0.21M-0.26M0.04M
Change in Cash 0.42M-0.40M1.93M-0.66M-0.01M2.40M-1.63M
Beginning Cash Balance 0.84M1.26M0.86M2.79M2.12M2.12M4.52M
Free Cash Flow -0.23M-0.23M0.13M0.01M0.50M-1.97M-2.46M
Net Cash Flow 0.42M-0.41M1.87M-0.51M0.21M2.66M-1.67M